title: Enhancing the Benefit of Bivalirudin in Percutaneous Coronary Intervention: Is High Risk of Bleeding the Key?
authors.affiliation: Division of Cardiology and Cardiovascular Pathophysiology, Hospital "S.M. della Misericordia", 06132, Perugia, Italy.
authors.forename: Fabio
authors.initials: F
authors.lastname: Angeli
authors.forename: Gianpaolo
authors.initials: G
authors.lastname: Reboldi
mesh_terms: D000991:Antithrombins / Q000008:administration & dosage / Q000009:adverse effects / Q000493:pharmacokinetics; D001777:Blood Coagulation / Q000187:drug effects; D023903:Coronary Restenosis / Q000209:etiology / Q000517:prevention & control; D006470:Hemorrhage / Q000139:chemically induced*; D006629:Hirudins / Q000008:administration & dosage / Q000009:adverse effects / Q000493:pharmacokinetics; D006801:Humans; D010446:Peptide Fragments / Q000008:administration & dosage / Q000009:adverse effects / Q000493:pharmacokinetics; D062645:Percutaneous Coronary Intervention / Q000379:methods*; D010974:Platelet Aggregation / Q000187:drug effects; D011183:Postoperative Complications / Q000517:prevention & control*; D011994:Recombinant Proteins / Q000008:administration & dosage / Q000009:adverse effects / Q000493:pharmacokinetics; D018570:Risk Assessment
chemical_list: D000991:Antithrombins; D006629:Hirudins; D010446:Peptide Fragments; D011994:Recombinant Proteins; C074619:bivalirudin